Cargando…
Should Women with Polycystic Ovarian Syndrome be Prioritized to Receive the COVID Vaccine?
Autor principal: | Shah, Duru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279054/ https://www.ncbi.nlm.nih.gov/pubmed/34316242 http://dx.doi.org/10.4103/jhrs.jhrs_78_21 |
Ejemplares similares
-
Polycystic ovarian morphology in Thai women of reproductive age with polycystic ovary syndrome
por: Wongwananuruk, Thanyarat, et al.
Publicado: (2020) -
Consensus Statement on the Use of Oral Contraceptive Pills in Polycystic Ovarian Syndrome Women in India
por: Shah, Duru, et al.
Publicado: (2018) -
Age-Adjusted Prevalence and Characteristics of Women with Polycystic Ovarian Syndrome in Korea: A Nationwide Population-Based Study (2010–2019)
por: Kim, Ju Hee, et al.
Publicado: (2022) -
The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016) -
Polycystic Ovary Syndrome and COVID-19: An Emerging Risk Factor
por: Joshi, Shashank R.
Publicado: (2021)